Effects of dietary intervention on MRI activity, de- and remyelination in the cuprizone model for demyelination

Experimental Neurology

Volumn 215, Issue 1, 2009, Pages 160-166

  Torkildsen, Øivind ^a,b   Brunborg, Linn Anne ^c   Thorsen, Frits ^b   Mørk, Sverre Jarl ^a,b   Stangel, Martin ^d   Myhr, Kjell Morten ^a,b   Bø, Lars ^a,b  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c INSTITUTE OF MARINE RESEARCH   (Norway)

^d HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Animal model; Cuprizone; Demyelination; Multiple sclerosis; n 3 fatty acids; Remyelination

Indexed keywords

COD LIVER OIL; CUPRIZONE; POLYUNSATURATED FATTY ACID; SOYBEAN OIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTOSIS; BLOOD BRAIN BARRIER; CONTROLLED STUDY; CORPUS CALLOSUM; DEMYELINATING DISEASE; DEMYELINATION; DIET THERAPY; DIETARY INTAKE; EXPERIMENTAL MODEL; FEMALE; FISH; FOOD COMPOSITION; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MOUSE; MULTIPLE SCLEROSIS; NEUROPROTECTION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REMYELINIZATION; SALMON;

ANIMALS; ANTIGENS, DIFFERENTIATION; CORPUS CALLOSUM; CUPRIZONE; DEMYELINATING DISEASES; DISEASE MODELS, ANIMAL; FATTY ACIDS, UNSATURATED; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; INDOLES; INJECTIONS, INTRAVENOUS; MAGNETIC RESONANCE IMAGING; MICE; MICE, INBRED C57BL; MYELIN PROTEOLIPID PROTEIN; RECOVERY OF FUNCTION; STATISTICS, NONPARAMETRIC;

EID: 57449088363     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2008.09.026     Document Type: Article

References (34)

1. Agranoff B.W., and Goldberg D. Diet and the geographical distribution of multiple sclerosis. Lancet 2 (1974) 1061-1066
2. Ascherio A., and Munger K.L. Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors. Ann. Neurol. 61 (2007) 504-513
3. Bates D., Fawcett P.R., Shaw D.A., and Weightman D. Polyunsaturated fatty acids in treatment of acute relapsing remitting multiple sclerosis. Br. Med. J. 2 (1978) 1390-1391
4. Berkow S.E., and Campagnoni A.T. Essential fatty acid deficiency: effects of cross-fostering mice at birth on myelin levels and composition. J. Nutr. 113 (1983) 582-592
5. Breij E.C.W., Brink B.P., Veerhuis R., van den Berg C., Vloet R., Yan R., Dijkstra C.D., van der Valk P., and Bø L. Homogeneity of active demyelinating lesions in established multiple sclerosis. Ann. Neurol. 63 (2008) 16-25
6. Carlton W.W. Studies on the induction of hydrocephalus and spongy degeneration by cuprizone feeding and attempts to antidote the toxicity. Life Sci. 6 (1967) 9-11
7. Cercedo L.R., Panzarella F.P., Vasta A.B., and DeRenzo E.C. Studies on essential fatty acid deficiency in three strains of mice. J. Nutr. 48 (1952) 41-47
8. Does M.D., and Gore J.C. Compartmental study of T1 and T2 in rat brain and trigeminal nerve in vivo. Magn. Reson. Med. 47 (2002) 274-283
9. Elvevoll E.O., Barstad H., Breimo E.S., Brox J., Eilertsen K.E., Lund T., Olsen J.O., and Osterud B. Enhanced incorporation of n - 3 fatty acids from fish compared with fish oils. Lipids 41 (2006) 1109-1114
10. Espaza M.L., Sasaki S., and Kesteloot H. Nutrition, latitude, and multiple sclerosis mortality: an ecological study. Am. J. Epidemiol. 142 (1995) 733-737
11. Farinotti M., Simi S., Di Pietrantonj C., McDowell N., Brait L., Lupo D., and Filippini G. Dietary interventions for multiple sclerosis. Cochrane Database Syst. Rev. 24 (2007) CD004192
12. Ghadirian P., Jain M., Ducic S., Shatenstein B., and Morisset R. Nutritional factors in the aetiology of multiple sclerosis: a case-control study in Montreal, Canada. Int. J. Epidemiol. 27 (1998) 845-852
13. Harris W.S., Pottala J.V., Sands S.A., and Jones P.G. Comparison of the effects of fish and fish-oil capsules on the n 3 fatty acid content of blood cells and plasma phospholipids. Am. J. Clin. Nutr. 86 (2007) 1621-1625
14. Irvine K.A., and Blakemore W.F. Remyelination protects axons from demyelination-associated axon degeneration. Brain 131 (2008) 1464-1477
15. Kampman M.T., Wilsgaard T., and Mellgren S.I. Outdoor activities and diet in childhood and adolescence relate to MS risk above the arctic circle. J. Neurol. 254 (2007) 471-477
16. Katsel P., Davis K.L., and Haroutunian V. Variations in myelin and oligodendrocyte-related gene expression across multiple brain regions in schizophrenia: a gene ontology study. Schizophr. Res. 79 (2005) 157-173
17. Kesterson J.W., and Carlton W.W. Cuprizone toxicosis in mice-attempts to antidote the toxicity. Toxicol. Appl. Pharmacol. 22 (1972) 6-13
18. Kuhlmann T., Lingfeld G., Bitsch A., Schuchardt J., and Bruck W. Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time. Brain 125 (2002) 2202-2212
19. Lauer K. The risk of multiple sclerosis in the USA in relation to sociogeographic features: a factor-analytical study. J. Clin. Epidemiol. 47 (1994) 43-48
20. Lindner M., Heine S., Haastert K., Garde N., Fokuhl J., Linsmeier F., Grothe C., Baumgaertner W., and Stangel M. Sequential myelin protein expression during remyelination reveals fast and efficient repair after central nervous system demyelination. Neuropathol. Appl. Neurobiol. 34 (2008) 105-114
21. Merkler D., Boretius S., Stadelmann C., Ernsting T., Michaelis T., Frahm J., and Brück W. Multicontrast MRI of remyelination in the central nervous system. NMR Biomed. 18 (2005) 395-403
22. Nordvik I., Myhr K.M., Nyland H., and Bjerve K.S. Effect of dietary advice and n - 3 supplementation in newly diagnosed MS patients. Acta Neurol. Scand. 102 (2000) 143-149
23. Paty D.W., Cousin H.K., Read S., and Adlakha K. Linoleic acid in multiple sclerosis: failure to show any therapeutic benefit. Acta Neurol. Scand. 58 (1978) 53-58
24. Simopoulos A.P., Leaf A., and Slame Jr. N. Workshop statement on the essentiality of and recommended dietary intakes for Omega-6 and Omega-3 fatty acids. Prostaglandins Leukot. Essent. Fat. Acids 63 (2000) 119-121
25. Skripuletz T., Lindner M., Kotsiari A., Garde N., Fokuhl J., Linsmeier F., Trebst C., and Stangel M. Cortical demyelination is prominent in the murine cuprizone model and is strain-dependent. Am. J. Pathol. 172 (2008) 1053-1061
26. Swank R.L. Multiple sclerosis; a correlation of its incidence with dietary fat. Am. J. Med. Sci. 220 (1950) 421-430
27. Swank R.L., Lerstad O., Strom A., and Backer J. Multiple sclerosis in rural Norway its geographic and occupational incidence in relation to nutrition. New Engl. J. Med. 246 (1952) 722-728
28. Swank R.L., and Dugan B.B. Effect of low saturated fat diet in early and late cases of multiple sclerosis. Lancet 336 (1990) 37-39
29. Torkildsen Ø., Brunborg L.A., Myhr K.M., and Bø L. The cuprizone model for demyelinisation. Acta Neurol. Scand., Suppl. 188 (2008) 72-76
30. Totoiu M.O., Nistor G.I., Lane T.E., and Keirstead H.S. Remyelination, axonal sparing, and locomotor recovery following transplantation of glial-committed progenitor cells into the MHV model of multiple sclerosis. Exp. Neurol. 187 (2004) 254-265
31. Trapp B.D., Peterson J., Ransohoff R.M., Rudick R., Mork S., and Bo L. Axonal transection in the lesions of multiple sclerosis. N. Engl. J. Med. 338 (1998) 278-285
32. Visioli F., Risé P., Barassi M.C., Marangoni F., and Galli C. Dietary intake of fish vs formulations leads to higher plasma concentrations of n - 3 fatty acids. Lipids 38 (2003) 415-418
33. Xiao L., Xu H., Zhang Y., Wei Z., He J., Jiang W., Li X., Dyck L.E., Devon R.M., Deng Y., and Li X.M. Quetiapine facilitates oligodendrocyte development and prevents mice from myelin breakdown and behavioural changes. Mol. Psychiatry 13 (2008) 697-708
34. Zhang S.M., Willett W.C., Hernan M.A., Olek M.J., and Ascherio A. Dietary fat in relation to risk of multiple sclerosis among two large cohorts of women. Am. J. Epidemiol. 152 (2000) 1056-1064